— Know what they know.
Not Investment Advice

VRPX OTC

Virpax Pharmaceuticals, Inc.
1W: +0.0% 1M: +11000.0% 3M: +0.0% YTD: +0.9% 1Y: -55.6% 3Y: -100.0% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $13792 mcap · 1M float · 0.043% daily turnover · Short 43% of daily vol

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2024-02-27
Earliest Filing
2024-02-27
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named VRPX in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
SCLXW Scilex Holding Co partner Defendant in litigation and counterparty to settlement agreement involving payments and royalty obligations. 2024-02-27 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms